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UPON ACUTE CYSTITIS ： A STUDY BY DOUBLE BLIND METHOD
Masuya MiuRA， Kanji NAKAGAwA， Tsuneo OyAMATsu， Masuhiro NoDA，
         Keiko FuKuTANi and Seiz6 HoRiucHi
From the DePartment一 of Urology， Tokyo Teislzin Hospital， Tofeyo
       （Chief： Dr． S． Horiuchi， M． D．）
  Clinical effects of cephalexin （CEX）， cephaloglycin （CEG） and ampicillin （AB－PC） were
comparatively studied in 45 cases of acute cystitis． Doubユe bユind method was adopted in this
study and the following results were obtained．
  1） CEG was administered 1 gram per day for five days， CEX， same， and AB－PC 2 grams
per day for five days． All of them were clinically effective， and there was no significant dif－
ference among their effects according to our statistical 一analysis．
  2） MIC was measured in 42 strains of E． coli， and the following order of activity was
proved ： CER＞CEG＞AB－PC＞CEX＞TC＞CP．
  3） Side effect was observed in one patient of each group of CEG， CEX or AB－PC． lt was
’so slight that medication was not discontinued．
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三浦・ほか：急性膀胱炎に対するCephalosporin CとAmpicillin























CEG 19／日投与群， CEX 19／日投与群およびAB－
PC 29／日投与群についてX2－testを行なってみると
Table 3のごとくになる．












































co1（CP）， tetracycline（TC）， CER， CEG， CEXお
よびAB－PCについて測定した結果をTable 4に示
した．
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Fig，2． Correlationship between disごzone diameter and MIC of CEX（E． coli）．







































性膀胱炎のnalidixic acid 1，59／日と， nalidi－
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